Reply to the Comment on “Design, synthesis, anticancer activity and molecular docking of quinoline-based dihydrazone derivatives” by R. Weiskirchen, RSC Adv., 2025, 15, https://doi.org/10.1039/D5RA00388A

Abstract

In this reply, Lu et al. address the cell line contamination concerns raised in the comment on their original paper (RSC Adv., 2025, 15, 231–243). To ensure the reliability of their conclusions, the key experiments were repeated using authenticated cell lines (Huh-7 and HUVEC), confirming the reproducibility and validity of the reported results.